SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-023319
Filing Date
2021-05-04
Accepted
2021-05-04 16:03:45
Documents
6
Period of Report
2021-04-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20210428.htm 8-K 76051
2 EX-3.1 life-ex31_14.htm EX-3.1 9632
3 EX-5.1 life-ex51_118.htm EX-5.1 18622
4 EX-10.1 life-ex101_152.htm EX-10.1 109463
5 GRAPHIC gcehvlaryczp000001.jpg GRAPHIC 34850
6 GRAPHIC gcehvlaryczp000002.jpg GRAPHIC 34413
  Complete submission text file 0001564590-21-023319.txt   310588
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 21888331
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences